The company reported revenue of $10.97 billion and earnings of $1.34 on a per-share and adjusted basis, compared to the consensus estimates of $11.01 billion and ...

Abbott Laboratories’ ABT growth in the fourth quarter of 2024 can be attributed to strong improvement in global Core ...

ABT currently has a PEG ratio of 2.43. Another notable valuation metric for HAE is its P/B ratio of 4.28. Investors use the P/B ratio to look at a stock's market value versus its book value ...

ABBOTT LABORATORIES (ABT) is a large-cap growth stock in the Medical Equipment & Supplies industry. The rating using this strategy is 68% based on the firm’s underlying fundamentals and the ...

Oppenheimer has recently initiated Abbott Laboratories (ABT) stock to Outperform rating, as announced on October 8, 2024, according to Finviz. Earlier, on September 19, 2024, Piper Sandler had ...

Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 0.66% of ...

75.18% of the stock is currently owned by institutional investors and hedge funds. Several brokerages have issued reports on ABT. Oppenheimer initiated coverage on shares of Abbott Laboratories in ...

Abbott Laboratories’ ABT growth in the fourth quarter of 2024 ... Each was handpicked by a Zacks expert as the #1 favorite stock to gain +100% or more in 2024. While not all picks can be winners ...

ABT currently has a PEG ratio of 2.68. Another notable valuation metric for PBH is its P/B ratio of 2.39. The P/B is a method of comparing a stock's market value to its book value, which is defined as ...